期刊
CELLULAR AND MOLECULAR NEUROBIOLOGY
卷 42, 期 2, 页码 455-472出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-021-01047-w
关键词
Stroke; Gut microbiota; Microbiota-gut-brain axis; Stroke risk factors
资金
- National Natural Science Foundation of China [81774059]
- Tianjin Natural Science Foundation [19JCZDJC37100]
Stroke is a lethal neurological disease that poses a grave economic burden on society, yet there remains an absence of precise effective treatment strategies. The gut microbiota plays a significant role in stroke prevention and treatment, with interventions through symbiotic microorganisms showing promise in improving stroke prognosis.
Stroke, a lethal neurological disease, accounts for a grave economic burden on society. Despite extensive basic and clinical studies on stroke prevention, a precise effective treatment approach for stroke at this stage remains unavailable. The majority of our body's gut microbiota plays a vital role in food digestion, immune regulation, and nervous system development, which is highly associated with the development of some diseases. Multiple clinical studies have documented variation in the composition of gut microbiota between stroke patients and healthy counterparts. Moreover, the intervention of intestinal symbiotic microorganisms via several mechanisms plays an active role in stroke prognosis. In the prevention and treatment of stroke, the gut microbiota gives off a seductive glow, this is a promising therapeutic target. This paper summarizes the current knowledge of stroke and gut microbiota, and systematically describes the possible mechanisms of interaction between stroke and gut microbiota, the relationship between stroke-related risk factors and gut microbiota, and the treatment of gut flora using microorganisms. Thus, it could valuably elucidate the correlation of gut microbiota with stroke incidence, providing stroke researchers with a new strategy for stroke prevention and treatment by regulating gut microbiota.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据